Janux Therapeutics, Inc. (NASDAQ: JANX) reported Q1 EPS of ($0.38), $0.01 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Janux Therapeutics, Inc. (JANX) click here.